Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Oncotarget
|
April 7, 2015
miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway
Chunlei Ge, Shikai Wu, Weiwei Wang, et al.
Oncology Reports
|
August 22, 2019
Curcumin inhibits cell proliferation and migration in NSCLC through a synergistic effect on the TLR4/MyD88 and EGFR pathways
Lanfeng Zhang, Xingyu Tao, Qiaofen Fu, et al.
BMC Cancer
|
December 23, 2017
Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
Chunlei Ge, Ruilei Li, Haifeng Song, et al.
Human Mutation
|
December 3, 2021
The enhancer rare germline variation rs548071605 contributes to lung cancer development
Xuchun Wang, He Cheng, Yin Yang, et al.
The American Journal of Pathology
|
September 13, 2015
miR-506 Inhibits Epithelial-to-Mesenchymal Transition and Angiogenesis in Gastric Cancer
Zhen Li, Zhimin Liu, Suwei Dong, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
September 3, 2016
Safety and Efficacy of Transplantation with Allogeneic Skin Tumors to Treat Chemically-Induced Skin Tumors in Mice
Zhiwei Zhang, Hua Sun, Jianhua Zhang, et al.
Translational Cancer Research
|
February 4, 2022
Anticancer effect of the traditional Chinese medicine herb Maytenus compound via the EGFR/PI3K/AKT/GSK3β pathway
Baozhen Zeng, Chunlei Ge, Wentao Zhao, et al.
Frontiers in Oncology
|
February 19, 2021
CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin's Lymphoma
YuanBo Xue, Xun Lai, RuiLei Li, et al.
Genome Biology
|
May 26, 2019
The inherited variations of a p53-responsive enhancer in 13q12.12 confer lung cancer risk by attenuating TNFRSF19 expression
Lipei Shao, Xianglin Zuo, Yin Yang, et al.
Molecular Oncology
|
February 22, 2018
IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancer
Jiang-Jiang Li, Ruilei Li, Wenxiang Wang, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Oncotarget
|
April 7, 2015
miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway
Chunlei Ge, Shikai Wu, Weiwei Wang, et al.
Oncology Reports
|
August 22, 2019
Curcumin inhibits cell proliferation and migration in NSCLC through a synergistic effect on the TLR4/MyD88 and EGFR pathways
Lanfeng Zhang, Xingyu Tao, Qiaofen Fu, et al.
BMC Cancer
|
December 23, 2017
Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
Chunlei Ge, Ruilei Li, Haifeng Song, et al.
Human Mutation
|
December 3, 2021
The enhancer rare germline variation rs548071605 contributes to lung cancer development
Xuchun Wang, He Cheng, Yin Yang, et al.
The American Journal of Pathology
|
September 13, 2015
miR-506 Inhibits Epithelial-to-Mesenchymal Transition and Angiogenesis in Gastric Cancer
Zhen Li, Zhimin Liu, Suwei Dong, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
September 3, 2016
Safety and Efficacy of Transplantation with Allogeneic Skin Tumors to Treat Chemically-Induced Skin Tumors in Mice
Zhiwei Zhang, Hua Sun, Jianhua Zhang, et al.
Translational Cancer Research
|
February 4, 2022
Anticancer effect of the traditional Chinese medicine herb Maytenus compound via the EGFR/PI3K/AKT/GSK3β pathway
Baozhen Zeng, Chunlei Ge, Wentao Zhao, et al.
Frontiers in Oncology
|
February 19, 2021
CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin's Lymphoma
YuanBo Xue, Xun Lai, RuiLei Li, et al.
Genome Biology
|
May 26, 2019
The inherited variations of a p53-responsive enhancer in 13q12.12 confer lung cancer risk by attenuating TNFRSF19 expression
Lipei Shao, Xianglin Zuo, Yin Yang, et al.
Molecular Oncology
|
February 22, 2018
IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancer
Jiang-Jiang Li, Ruilei Li, Wenxiang Wang, et al.
Page
of 3